Robert Breuil
Keine laufenden Positionen mehr
Vermögen: 186 875 $ am 30.04.2024
Profil
Robert S.
Breuil served as the Director of Corporate Planning, Analysis & Controller at ALZA Corp.
He then worked as the Chief Financial Officer & VP of Corporate Development at Aerogen, Inc. from 2002 to 2005.
From 2006 to 2009, he held the position of Chief Financial Officer & Senior Vice President of Finance at Codexis, Inc. He later became the Chief Financial Officer at Graybug Vision, Inc. In 2012, he joined Corium International, Inc. as the Chief Financial Officer, a position he held until 2019.
Prior to these roles, he worked as a Controller at ALZA Pharmaceuticals and as the Chief Financial Officer & Treasurer at CalciMedica, Inc. Mr. Breuil completed his undergraduate degree at the United States Naval Academy in 1983.
He then obtained an MBA from Stanford Graduate School of Business in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CALCIMEDICA, INC.
0,33% | 31.03.2024 | 35 326 ( 0,33% ) | 186 875 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Robert Breuil
| Unternehmen | Position | Ende |
|---|---|---|
| CORIUM INTERNATIONAL INC | Finanzdirektor/CFO | 01.08.2019 |
| CODEXIS, INC. | Finanzdirektor/CFO | - |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Finanzdirektor/CFO | 01.01.2005 |
| CALCIMEDICA, INC. | Finanzdirektor/CFO | - |
| CALCIMEDICA, INC. | Finanzdirektor/CFO | - |
Ausbildung von Robert Breuil
| United States Naval Academy | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CODEXIS, INC. | Process Industries |
| CALCIMEDICA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Aerogen, Inc.
Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| ALZA Pharmaceuticals | |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
